Skip to main content
OpenTrials
Completed

NCT Number: NCT05274490

COPD Prognosis in Covid Patients

In this prospective observational study, patients were selected from attendees of the intensive care unit. Different measures and outcomes had been studied and compared between patients with and without COPD, including hospitalization, medical costs, length of Intensive care stay, respiratory failure, and death rate.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: more than 20 years old.
  • Both Males and females will be included.
  • COPD patients.
  • Recent confirmed the diagnosis with SARS-COV-2.

Exclusion criteria

  • Pregnancy.
  • Malignancy.
  • Immunodeficiency disease

Treatment and study plan

intubation and mechanical ventilation

Procedure

patients who were in need were intubated and mechanically ventilated

Primary outcomes

  1. SOFA score measurement in both groups

    Time frame: 2 weeks

    monitoring of SOFA items along two weeks

Secondary outcomes

  1. prognosis of the disease

    Time frame: 2 weeks

    hospital stay, nedd for mechanical ventilation

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Chronic Obstructive Pulmonary Disease Prognosis in Sars-covid 2 Infection

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Mar 10, 2022
Registry last updated
Mar 10, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.